Sort
51,593 grants matching “hepatitis”
Xenobiotic Receptors
$848,152Frank J Gonzalez · Basic Sciences · Z01 · FY2007 · CA
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
$847,979Jean E Schaffer · Joslin Diabetes Center · DP1 · FY2019 · DK
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$847,913Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2020 · AI
Preclinical Development of a Novel and Powerful Immunotherapeutic
$847,617Susan Dana Jones · Immurx Llc · R44 · FY2012 · AI
Biorepository for Genomic Medicine in diverse Communities
$847,500Erwin P. Bottinger · Icahn School Of Medicine At Mount Sinai · U01 · FY2011 · HG
First-in-human study of a potent anti-HBsAg neutralizing antibody
$847,498Marina Caskey · Rockefeller University · U01 · FY2024 · AI
HBV cccDNA and integrated DNA in HIV coinfection and HBV monoinfection
$847,428Daryl T Lau · Beth Israel Deaconess Medical Center · R56 · FY2023 · AI
Immune Control and Evasion during Acute HCV Infection
$847,330Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2013 · AI
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$847,201Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio
$847,166William C Miller · Ohio State University · UH3 · FY2021 · DA
Center for the Study of Innate Immunity to HCV Infection
$847,117Michael J Gale · University Of Washington · U19 · FY2011 · AI
P75 Small Molecule Ligands for Alzheimer's Therapy
$847,101Frank M Longo · Stanford University · U01 · FY2008 · AG
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
$846,461Thomas E Lane · University Of California-Irvine · R35 · FY2024 · NS
Structural Biology Of Virus Assembly
$846,167Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users
$846,122Sherry Deren · New York University · P30 · FY2009 · DA
Drug Abuse Treatment System Survey
$845,381University Of Michigan At Ann Arbor · R01 · FY2005 · DA
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$845,326Christopher D Heaney · Johns Hopkins University · R01 · FY2020 · ES
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$845,274Michael R Grever · Ohio State University · UM1 · FY2015 · CA
HIV Risks and Transitions to Injection among Non-IDUs
$844,668Universidad Central Del Caribe · R01 · FY2004 · DA
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
$844,561Tracey Simon · Brigham And Women'S Hospital · R01 · FY2025 · HL
Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection
$844,040Ada S Cowan · Metallopharm, Llc · R44 · FY2011 · AA
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$843,593University Of Louisiana At Lafayette · U42 · FY2002 · RR
A new humanized mouse model to study HBV gene editing
$843,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$843,127Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Endocannabinoids And The Control Of Cardiovascular Function
$843,054George Kunos · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA